Reevaluation and Update on Efficacy and Safety of Neostigmine for Reversal of Neuromuscular Blockade
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s179420
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2018
Authors
Publisher
Informa UK Limited